US equities |
SPCX $174.25 ▲+1.85% NVDA $241.91 ▲+1.26% MU $1,067.45 ▲+0.33% MRVL $295.05 ▲+8.78% AMD $642.50 ▲+1.70% SNDK $1,681.65 ▼-1.32% TSLA $380.26 ▲+0.40% META $740.00 ▼-0.26%
FinancialContent

Latest News about Genetic Disorder

Recent news which mentions Genetic Disorder

Quoin Outlicenses Lead Asset For Skin Disorder In Middle East, North Africa
Tickers QNRX
Tags Biotech Movers Contracts
From Benzinga
Quoin, AFT Pharmaceuticals Ink Licensing Pact For Lead Candidate In Genetic Skin Disease
Tickers QNRX
Tags QNRX General Biotech
From Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
Tickers VRTX
Tags Genetic Disorder VRTX News
From Benzinga
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate
Tickers MITO
Tags MITO Health Care Briefs
From Benzinga
PTC Therapeutics' Rare Genetic Disease Gene Therapy Shows Durable Improvement Even At 5 Years
Tickers PTCT
Tags News Briefs Market News
From Benzinga
Eli Lilly Inks Another RNA Collab, This Time With ProQR
Tickers LLY PRQR
Tags LLY Contracts News
From Benzinga
AstraZeneca's Drug Shows Promise In Copper Build-Up Genetic Disease
Tickers AZN AZNCF
Tags General Benzinga AZN
From Benzinga
Stealth Bio Files US Application For Ultra Rare Genetic Disease Candidate
Tickers MITO
Tags MITO FDA News
From Benzinga
PTC Therapeutics' Waylivra Scores Approval In Brazil For Genetic Disorder
Tickers IONS PTCT
Tags Benzinga PTCT Biotech
From Benzinga
Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
Tickers CYTH
Tags CYTH Biotech Benzinga
From Benzinga